Cargando…

When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis

Thrombocytopenia can arise from various conditions, including myelodysplastic syndromes (MDS) and bone marrow failure (BMF) syndromes. Meticulous assessment of the peripheral blood smear, identification of accompanying clinical conditions, and characterization of the clinical course are important fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonadies, Nicolas, Rovó, Alicia, Porret, Naomi, Bacher, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958851/ https://www.ncbi.nlm.nih.gov/pubmed/33801484 http://dx.doi.org/10.3390/jcm10051026

Ejemplares similares

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
por: Njue, Linet, et al.
Publicado: (2020)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult—A Case Report and Review of the Literature
por: Dorenkamp, Moritz, et al.
Publicado: (2023)

Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
por: Chanias, Ioannis, et al.
Publicado: (2021)

Should we always improve adherence to antimicrobial treatment? I don’t think we should
por: Llor, Carles
Publicado: (2014)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

Should we recommend PEC and when?
por: Coron, Emmanuel
Publicado: (2016)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

Thyroid toxicology and brain development: should we think differently?
por: Zoeller, R Thomas
Publicado: (2003)

How should we think about clinical data ownership?
por: Ballantyne, Angela
Publicado: (2020)

Musculoskeletal pain in children, should we think about neuroblastoma?
por: Sadeghi, Payman, et al.
Publicado: (2022)

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

Acquired spherocytosis in the setting of myelodysplasia
por: Karlsson, Linda Katharina, et al.
Publicado: (2022)

An Unusual Case of Heart Failure: Sometimes When You Hear Hoof Beats You Should Think of Zebras
por: Butt, Edward J, et al.
Publicado: (2021)

Myelodysplasia in the setting of paroxysmal nocturnal hemoglobinuria: Interpretation of blast percentage in a marrow with erythroid hyperplasia
por: Groarke, Emma M., et al.
Publicado: (2020)

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia
por: Raaijmakers, Marc H.G.P., et al.
Publicado: (2010)

Platelet volume indices have low diagnostic efficiency for predicting bone marrow failure in thrombocytopenic patients
por: XU, RUI-LONG, et al.
Publicado: (2013)

Occupational lung disease: when should I think of it and why is it important?
por: Feary, Johanna, et al.
Publicado: (2023)

Chronic Renal Failure Secondary to Unrecognized Neurogenic Bladder in A Child with Myelodysplasia
por: AHMED, Shameem, et al.
Publicado: (2017)

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
por: Heini, Alexander D., et al.
Publicado: (2021)

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
por: Seipel, Katja, et al.
Publicado: (2022)

Negative patch tests: what should we think about these results?()
por: Starck, Mellanie, et al.
Publicado: (2022)

NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients
por: Jalowiec, Katarzyna Aleksandra, et al.
Publicado: (2021)

New Insights on Iron Study in Myelodysplasia
por: El Husseiny, Noha M., et al.
Publicado: (2014)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
por: Rentsch, Vera, et al.
Publicado: (2022)

Less Graft-Versus-Host Disease after Rabbit Antithymocyte Globulin Conditioning in Unrelated Bone Marrow Transplantation for Leukemia and Myelodysplasia: Comparison with Matched Related Bone Marrow Transplantation
por: Atta, Elias Hallack, et al.
Publicado: (2014)

What We Think About When We Think About Triffids: The Monstrous Vegetal in Post-war British Science Fiction
por: Matthews, Graham J.
Publicado: (2016)

Debate: Unstable angina - When should we intervene?
por: Kereiakes, Dean J
Publicado: (2000)

Plasma in the PICU: why and when should we transfuse?
por: Labarinas, Sonia, et al.
Publicado: (2013)

When Should We Interfere in Threatened Puerperal Convulsions?
por: Richardson, Everard H.
Publicado: (1891)

When Should We Interfere in Threatened Puerperal Convulsions
por: Richardson, Everard H.
Publicado: (1891)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Metformin: When Should We Fear Lactic Acidosis?
por: Di Mauro, Stefania, et al.
Publicado: (2022)

Should we think about wrist extensor after flexor tendon repair?
por: Ferreira, Aline M, et al.
Publicado: (2013)

Should We All be Scientists? Re-thinking Laboratory Research as a Calling
por: Bezuidenhout, Louise, et al.
Publicado: (2017)

Should we teach computational thinking and big data principles to medical students?
por: Saqr, Mohammed, et al.
Publicado: (2019)

How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes?
por: Deem, Jennifer D., et al.
Publicado: (2017)

The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
por: Kurkinen, Markku, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1d25laosb9d4rb0tg050hp5dmj